Stress and arousal (original) (raw)

• de Lecea L., Kilduff T. S., Peyron C., et al. (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 95, 322–327.
  Article PubMed Google Scholar
• Sakurai T., Amemiya A., Ishii M., et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585.
  Article PubMed CAS Google Scholar
• Marcus J. N., Aschkenasi C. J., Lee C. E., et al. (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 435, 6–25.
  Article PubMed CAS Google Scholar
• Peyron C., Tighe D. K., van den Pol A. N., et al. (1998) Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems. J. Neurosci. 18, 9996–10,015.
  PubMed CAS Google Scholar
• Mignot E., Taheri S., and Nishino S. (2002) Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat. Neurosci. 5(Suppl), 1071–1075.
  Article PubMed CAS Google Scholar
• Willie J. T., Chemelli R. M., Sinton C. M., and Yanagisawa M. (2001) To eat or to sleep? orexin in the regulation of feeding and wakefulness. Annu. Rev. Neurosci. 24, 429–458.
  Article PubMed CAS Google Scholar
• Sutcliffe J. G. and de Lecea L. (2002) The hypocretins: setting the arousal threshold. Nat. Rev. Neurosci. 3, 339–349.
  Article PubMed CAS Google Scholar
• Scammell T. E. (2003) The neurobiology, diagnosis, and treatment of narcolepsy. Ann. Neurol. 53, 154–166.
  Article PubMed Google Scholar
• Lin L., Faraco J., Li R., et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365–376.
  Article PubMed CAS Google Scholar
• Chemelli R. M., Willie J. T., Sinton C. M., et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437–451.
  Article PubMed CAS Google Scholar
• Willie J. T., Chemelli R. M., Sinton C. M., et al. (2003) Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38, 715–730.
  Article PubMed CAS Google Scholar
• Hara J., Beuckmann C. T., Nambu T., et al. (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30, 345–354.
  Article PubMed CAS Google Scholar
• Beuckmann C. T., Sinton C. M., Williams S. C., et al. (2004) Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J. Neurosci. 24, 4469–4477.
  Article PubMed CAS Google Scholar
• Mieda M., Willie J. T., Hara J., Sinton C. M., Sakurai T., and Yanagisawa M. (2004) Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc. Natl. Acad. Sci. USA 101, 4649–4654.
  Article PubMed CAS Google Scholar
• Yamanaka A., Beuckmann C. T., Willie J. T., et al. (2003) Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38, 701–713.
  Article PubMed CAS Google Scholar
• Owens M. J. and Nemeroff C. B. (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43, 425–473.
  PubMed CAS Google Scholar
• Lubkin M. and Stricker-Krongrad A. (1998) Independent Feeding and Metabolic Actions of Orexins in Mice. Biochem. Biophys. Res. Commun. 253, 241–245.
  Article PubMed CAS Google Scholar
• Dube M. G., Kalra S. P., and Kalra P. S. (1999) Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res. 842, 473–477.
  Article PubMed CAS Google Scholar
• Haynes A. C., Jackson B., Overend P., et al. (1999) Effects of single and chronic intracere-broventricular administration of the orexins on feeding in the rat [In Process Citation]. Peptides 20, 1099–1105.
  Article PubMed CAS Google Scholar
• Sweet D. C., Levine A. S., Billington C. J., and Kotz C. M. (1999) Feeding response to central orexins. Brain Res. 821, 535–538.
  Article PubMed CAS Google Scholar
• Espana R. A., Plahn S., and Berridge C. W. (2002) Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res. 943, 224–236.
  Article PubMed CAS Google Scholar
• Estabrooke I. V., McCarthy M. T., Ko E., et al. (2001) Fos expression in orexin neurons varies with behavioral state. J. Neurosci. 21, 1656–1662.
  PubMed CAS Google Scholar
• Zeitzer J. M., Buckmaster C. L., Lyons D. M., and Mignot E. (2004) Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J. Physiol. 557, 1045–1053.
  Article PubMed CAS Google Scholar
• Balasko M., Szelenyi Z., and Szekely M. (1999) Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta. Physiol. Hung. 86, 219–222.
  PubMed CAS Google Scholar
• Yoshimichi G., Yoshimatsu H., Masaki T., and Sakata T. (2001) Orexin-A regulates body temperature in coordination with arousal status. Exp. Biol. Med. (Maywood) 226, 468–476.
  CAS Google Scholar
• Dun N. J., Le Dun S., Chen C. T., Hwang L. L., Kwok E. H., and Chang J. K. (2000) Orexins: a role in medullary sympathetic outflow. Regul. Pept. 96, 65–70.
  Article PubMed CAS Google Scholar
• Shirasaka T., Nakazato M., Matsukura S., Takasaki M., and Kannan H. (1999) Sympathetic and cardiovascular actions of orexins in conscious rats. Am. J. Physiol. 277, R1780-R1785.
  PubMed CAS Google Scholar
• Kayaba Y., Nakamura A., Kasuya Y., et al. (2003) Attenuated defense response and low basal blood pressure in orexin knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R581-R593.
  PubMed Google Scholar
• Blanco M., Garcia-Caballero T., Fraga M., et al. (2002) Cellular localization of orexin receptors in human adrenal gland, adrenocortical adenomas and pheochromocytomas. Regul. Pept. 104, 161–165.
  Article PubMed CAS Google Scholar
• Lopez M., Senaris R., Gallego R., et al. (1999) Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 140, 5991–5994.
  Article PubMed CAS Google Scholar
• Nanmoku T., Isobe K., Sakurai T., et al. (2002) Effects of orexin on cultured porcine adrenal medullary and cortex cells. Regul. Pept. 104, 125–130.
  Article PubMed CAS Google Scholar
• Sakamoto F., Yamada S., and Ueta Y. (2004) Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul. Pept. 118, 183–191.
  Article PubMed CAS Google Scholar
• Samson W. K., Taylor M. M., Follwell M., and Ferguson A. V. (2002) Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul. Pept. 104, 97–103.
  Article PubMed CAS Google Scholar
• Kuru M., Ueta Y., Serino R., et al. (2000) Centrally administered orexin/hypocretin activates HPA axis in rats. Neuroreport 11, 1977–1980.
  Article PubMed CAS Google Scholar
• Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., and Murakami N. (2000) Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 270, 318–323.
  Article PubMed CAS Google Scholar
• Ida T., Nakahara K., Kuroiwa T., et al. (2000) Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci. Lett. 293, 119–122.
  Article PubMed CAS Google Scholar
• Jaszberenyi M., Bujdoso E., Pataki I.. and Telegdy G. (2000) Effects of orexins on the hypothalamic-pituitary-adrenal system. J. Neuroendocrinol. 12, 1174–1178.
  Article PubMed CAS Google Scholar
• Espana R. A., Valentino R. J., and Berridge C. W. (2002) Fos expression in hypocretin-1 receptor-bearing and hypocretin-synthesizing neurons: effects of diurnal and nocturnal waking, stress and hcrt-1 administration. Abstract Viewer/Itinerary Planner. Society for Neuroscience., Program No. 776.5.
• Martins P. J., D’Almeida V., Pedrazzoli M., Lin L., Mignot E., and Tufik S. (2004) Increased hypocretin-1 (orexin-a) levels in cerebrospinal fluid of rats after short-term forced activity. Regul. Pept. 117, 155–158.
  Article PubMed CAS Google Scholar
• Reyes T. M., Walker J. R., DeCino C., Hogenesch J. B., and Sawchenko P. E. (2003) Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J. Neurosci. 23, 5607–5616.
  PubMed CAS Google Scholar
• Stricker-Krongrad A., Richy S., and Beck B. (2002) Orexins/hypocretins in the ob/ob mouse: hypothalamic gene expression, peptide content and metabolic effects. Regul. Pept. 104, 11–20.
  Article PubMed CAS Google Scholar
• Winsky-Sommerer R., Yamanaka A., Diano S., et al. (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J. Neurosci. 24, 11,439–11,448.
  Article CAS Google Scholar
• Samson W. K. and Taylor M. M. (2001) Hypocretin/orexin suppresses corticotroph responsiveness in vitro. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1140–1145.
  PubMed CAS Google Scholar
• Lu X. Y., Bagnol D., Burke S., Akil H., and Watson S. J. (2000) Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm. Behav. 37, 335–344.
  Article PubMed CAS Google Scholar
• Shirasaka T., Miyahara S., Kunitake T., et al. (2001) Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R1114-R1118.
  PubMed CAS Google Scholar
• Follwell M. J. and Ferguson A. V. (2002) Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J. Physiol. 545, 855–867.
  Article PubMed CAS Google Scholar
• Horvath T. L., Diano S., and van den Pol A. N. (1999) Synaptic interaction between hypocretin (Orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: A novel circuit implicated in metabolic and endocrine regulations. J. Neurosci. 19, 1072–1087.
  PubMed CAS Google Scholar
• Heilig M. (2004) The NPY system in stress, anxiety and depression. Neuropeptides 38, 213–224.
  Article PubMed CAS Google Scholar
• Adrian T. E., Allen J. M., Bloom S. R., et al. (1983) Neuropeptide Y distribution in human brain. Nature 306, 584–586.
  Article PubMed CAS Google Scholar
• Baldo B. A., Daniel R. A., Berridge C. W., and Kelley A. E. (2003) Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J. Comp. Neurol. 464, 220–237.
  Article PubMed Google Scholar
• Naveilhan P., Canals J. M., Valjakka A., Vartiainen J., Arenas E., and Ernfors P. (2001) Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism. Eur. J. Neurosci. 13, 2241–2246.
  Article PubMed CAS Google Scholar
• Bannon A. W., Seda J., Carmouche M., et al. (2000) Behavioral characterization of neuropeptide Y knockout mice. Brain Res. 868, 79–87.
  Article PubMed CAS Google Scholar
• Palmiter R. D., Erickson J. C., Hollopeter G., Baraban S. C., and Schwartz M. W. (1998) Life without neuropeptide Y. Rec. Prog. Horm. Res. 53, 163–199.
  PubMed CAS Google Scholar
• Karlsson R. M., Holmes A., Heilig M., and Crawley J. N. (2005) Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol. Biochem. Behav. 80, 427–436.
  Article PubMed CAS Google Scholar
• Fu L. Y., Acuña-Goycolea C.. and van den Pol A. N. (2004) Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J. Neurosci. 24, 8741–8751.
  Article PubMed CAS Google Scholar
• Kalivas P. W. and McFarland K. (2003) Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl.) 168, 44–56.
  Article CAS Google Scholar
• Koob G. F. (1999) Stress, corticotropin-releasing factor, and drug addiction. Ann. NY Acad. Sci. 897, 27–45.
  Article PubMed CAS Google Scholar
• Koob G. F., Sanna P. P., and Bloom F. E. (1998) Neuroscience of addiction. Neuron 21, 467–476.
  Article PubMed CAS Google Scholar
• Koob G. F. (2000) Neurobiology of addiction. Toward the development of new therapies. Ann. NY Acad. Sci. 909, 170–185.
  Article PubMed CAS Google Scholar
• Koob G. F. (1999) The role of the striatopallidal and extended amygdala systems in drug addiction. Ann. NY Acad. Sci. 877, 445–460.
  Article PubMed CAS Google Scholar
• Korotkova T. M., Eriksson K. S., Haas H. L., and Brown R. E. (2002) Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul. Pept. 104, 83–89.
  Article PubMed CAS Google Scholar
• Martin G., Fabre V., Siggins G. R., and de Lecea L. (2002) Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul. Pept. 104, 111–117.
  Article PubMed CAS Google Scholar
• Fadel J. and Deutch A. Y. (2002) Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111, 379–387.
  Article PubMed CAS Google Scholar
• Olds J. and Milner P. (1954) Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J. Comp. Physiol. Psychol. 47, 419–427.
  Article PubMed CAS Google Scholar
• Anand B. K. and Brobeck J. R. (1951) Localization of a feeding center in the hypothalamus of the rat. Proc. Soc. Exp. Biol. Med. 77, 323,324.
  PubMed CAS Google Scholar
• Gallistel C. R., Shizgal P., and Yeomans J. S. (1981) A portrait of the substrate for self-stimulation. Psychol. Rev. 88, 228–273.
  Article PubMed CAS Google Scholar
• Sarnyai Z., Shaham Y., and Heinrichs S. C. (2001) The role of corticotropin-releasing factor in drug addiction. Pharmacol. Rev. 53, 209–243.
  PubMed CAS Google Scholar
• Stricker-Krongrad A. and Beck B. (2002) Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids. Biochem. Biophys. Res. Commun. 296, 129–133.
  Article PubMed CAS Google Scholar
• Boutrel B., Kenny P. J., Winsky-Sommerer R., Markou A., Koob G. F., and de Lecea L. (2003) Soc. Neurosci. Abstr. 879.7.
• Macey D. J., Koob G. F. and Markou A. (2000) CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res. 866, 82–91.
  Article PubMed CAS Google Scholar
• Georgescu D., Zachariou V., Barrot M., et al. (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 23, 3106–3111.
  PubMed CAS Google Scholar
• Heinrichs S. C. and Koob G. F. (2004) Corticotropin-releasing factor in brain: a role in activation, arousal, and affect regulation. J. Pharmacol. Exp. Ther. 311, 427–440.
  Article PubMed CAS Google Scholar
• Aston-Jones G. and Harris G. C. (2004) Brain substrates for increased drug seeking during protracted withdrawal. Neuropharmacology 47(Suppl 1), 167–179.
  Article PubMed CAS Google Scholar
• Shalev U., Morales M., Hope B., Yap J. and Shaham Y. (2001) Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology (Berl.) 156, 98–107.
  Article CAS Google Scholar
• Lopez M., Seoane L., Garcia M. C., et al. (2000) Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem. Biophys. Res. Commun. 269, 41–45.
  Article PubMed CAS Google Scholar
• Yamamoto Y., Ueta Y., Date Y., et al. (1999) Down regulation of the prepro-orexin gene expression in genetically obese mice. Brain Res. Mol. Brain Res. 65, 14–22.
  Article PubMed CAS Google Scholar
• Cai X. J., Lister C. A., Buckingham R. E., et al. (2000) Down-regulation of orexin gene expression by severe obesity in the rats: studies in Zucker fatty and zucker diabetic fatty rats and effects of rosiglitazone. Brain Res. Mol. Brain Res. 77, 131–137.
  Article PubMed CAS Google Scholar
• Komaki G., Matsumoto Y., Nishikata H., et al. (2001) Orexin-A and leptin change inversely in fasting non-obese subjects. Eur. J. Endocrinol. 144, 645–651.
  Article PubMed CAS Google Scholar
• Rauch M., Riediger T., Schmid H. A., and Simon E. (2000) Orexin A activates leptin-responsive neurons in the arcuate nucleus. Pflugers Arch. 440, 699–703.
  Article PubMed CAS Google Scholar
• Thiele T. E., Sparta D. R., Hayes D. M., and Fee J. R. (2004) A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 38, 235–243.
  Article PubMed CAS Google Scholar
• Valdez G. R. and Koob G. F. (2004) Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism. Pharmacol. Biochem. Behav. 79, 671–689.
  Article PubMed CAS Google Scholar
• Koob G. F. (2003) Alcoholism: allostasis and beyond. Alcohol Clin. Exp. Res. 27, 232–243.
  Article PubMed CAS Google Scholar
• Roy A. and Pandey S. C. (2002) The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcohol Clin. Exp. Res. 26, 796–803.
  PubMed CAS Google Scholar
• Thiele T. E., Marsh D. J., Ste Marie L., Bernstein I. L., and Palmiter R. D. (1998) Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396, 366–369.
  Article PubMed CAS Google Scholar
• Koob G. F., Ahmed S. H., Boutrel B., et al. (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27, 739–749.
  Article PubMed CAS Google Scholar